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Regional differences in albuminuria among American Indians: An
epidemic of renal disease. Albuminuria is a risk factor for renal and
cardiovascular disease. We conducted a cross sectional survey of 4549
older American Indians in Arizona, Oklahoma and North and South
Dakota of (micro)albuminuria. A range of 20.1 to 48.3% of all participants
had either micro- ( 30 to <300 mg albumin/g creatinine) or macroalbu-
minuria ( 300 mg albumin/g creatinine). A total of 53% of the
participants were diabetic, and the prevalence in Arizona (65 to 70%) was
significantly greater than the other two Sites. Prevalence of micro- and
macroalbuminuria were significantly higher among those who were older,
diabetic or hypertensive, and participants from Arizona. Even normoten-
sive, nondiabetic Arizona Indians had higher prevalence rates than similar
participants elsewhere. Higher prevalence rates of micro- and macroalbu-
minuria were also found among Arizona participants than participants
with similar degrees of glucose intolerance from the other two sites.
Indians reporting the greatest degree of Indian blood were more likely to
have abnormal albuminuria (P < 0.0001). The duration of diabetes,
fasting plasma glucose, systolic blood pressure, fibrinogen and Indian
heritage were independently associated with micro- or macroalbuminuria.
The association of albuminuria with subsequent ESRD, cardiovascular
morbidity and overall mortality suggests that these American Indians will
face a large disease burden. The correlation with reported Indian blood
implies a strong component of genetic susceptibility, possibly independent
of diabetes.
Increased concentration of albumin in the urine of diabetic
individuals is a strong and independent predictor of all-cause and
coronary heart disease mortality [1, 2]. In comparison to a type 1
(insulin dependent) diabetic cohort whose urine contained nor-
mal amounts of albumin, patients with microalbuminuria faced
nearly a 200-fold increased risk of cardiovascular disease in the
decade following the initial observation [3, 4]. These findings led
to speculation that the albumin "leak" in the glomeruli reflects a
widespread capillary vasculopathy affecting the heart, eyes, and
perhaps other organs [5, 61. The appearance of nephropathy may
not be a simple consequence of diabetes. Family studies indicate
that diabetic nephropathy is more likely to occur among children
of parents with nephropathy, families with hypertension, or in
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siblings of patients with nephropathy [7—10]. Furthermore, the
presence of small, but abnormal amounts of albumin in the urine
is predictive of progression to overt nephropathy [11]. Thus,
measurements of albumin concentrations by sensitive techniques
are a valuable clinical, epidemiologic and public health tool.
The Strong Heart Study was begun in 1988 to measure risk
factors and cardiovascular disease among diverse groups of Amer-
ican Indians. The examination included an interview, physical
examination, collection of blood and urine, and a two-hour
glucose tolerance test. In light of the evolving importance of
albuminuria, sensitive measurements of urine albumin and creat-
mine were included in the phase-I examination. The expectation
was that the prevalence of albuminuria would be high, since
previous studies of certain American Indian populations reported
high rates of proteinuria [12, 13] and end-stage renal disease
[14—16]. In this paper, we summarize the prevalence rates of
albuminuria and its relation to other risk factors, and show data
indicating significant differences in the rates of albuminuria
among the three centers of the study.
Methods
Details summarizing design of this study [17], observed cardio-
vascular risk factors [18, 19] and prevalence of diabetes [20]
among the 4549 eligible participants are summarized in recent
publications. The Strong Heart Study population consisted of
4549 American Indians aged 45 to 74 years old living in Okla-
homa, South and North Dakota and Arizona. The examinations
occurred between July 1, 1989 and January 31, 1992. Percent
participation rates of the target population were 71% in Arizona,
53% in North and South Dakota and 62% in Oklahoma. The
participation rates were calculated using the total number of
persons in the December, 1988 tribal lists. Non-respondents did
not differ significantly from respondents in age, body mass index,
and self-reported incidence of diabetes or hypertension. A slightly
higher proportion of respondents were women compared to
non-respondents, and a higher proportion of the non-responders
were smokers.
Participants were members of the following tribes: Pima, Man-
copa and Tohono O'odham of central Arizona living in the Gila
River, Salt River and Ak-Chin Indian Communities; seven tribes
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Table 1. Prevalence of diabetes by age and site
Ariz
N of P
Age Sex subjects
ona
revalence
%
Okla
N of P
subjects
homa
revalence
%
Dak
N of P
subjects
otas
revalence
%
45—54 M 281
F 423
55—64 M 326
F 157
65—74 M 175
F 83
62.3
65.0
71.3
76.1
60.2
75.4
289
327
200
304
126
197
29.8
28.8
40.5
47.7
46.0
50.3
282
356
212
287
111
159
29.4
33.4
36.3
47.7
32.4
56.0
Total 1445 68.7 1443 39.0 1407 38.5
of Southwestern Oklahoma (Apache, Caddo, Comanche, Dela-
ware, Fort Sill Apache, Kiowa, and Wichita); and the Oglala and
Cheyenne River Sioux in South Dakota and the Devils Lake Sioux
in the Fort Totten area of North Dakota. The study received
approval of the Institutional Review Boards of the participating
institutions and Indian communities.
Briefly, the standardized clinical examination took place after a
twelve hour overnight fast. It consisted of a personal interview,
a physical examination including a 12-lead electrocardiogram,
and a review of current medications. A 75 gram oral glucose
tolerance test (OGIT; Glutol, Paddock Laboratory, Inc., Minne-
apolis, MN, USA) was performed, and blood was obtained two
hours later to measure plasma glucose. Participants were excluded
from the OG1IT if their fasting capillary glucose was 225 mg/dl
(AccuChek-Il, Baxter Health Care Corp., Grand Prairie, TX,
USA), or if previously diagnosed as having diabetes and currently
using an oral agent or insulin. Additionally, a small number of
participants who had chronic renal failure were excluded from the
glucose tolerance test. Participants were considered as having
diabetes if they were taking insulin or an oral hypoglycemic
medication, or if their fasting plasma glucose  140 mg/dl or their
two-hour plasma glucose  200 mg/dl [21]. Participants were
considered having impaired glucose tolerance if their fasting
plasma < 140 mg/dl and the two hours plasma glucose value 
140 and <200 mg/dl.
A random urine specimen was obtained on arrival to the clinic
(usually between 0800 and 0900 hr) for measurement of creatinine
and albumin content. Fasting blood was obtained for measure-
ment of plasma lipids and apolipoproteins, plasma glucose and
fibrinogen [22]. Each laboratory measurement was performed in a
central laboratory using stable methodology standardized to out-
side reference values. Serum and urine creatinine were measured
by the picric acid method [23]. Plasma glucose was measured on
the Hitachi 704, 705 or 717 autoanalyzer using a hexokinase
method (Boerhinger Mannheim/HK) standardized to controls
provided by the manufacturer (PreciCal, PreciNorm, PreciAb-
norm) and the College of American Pathologists. Urine albumin
content was measured by a sensitive, nephelometric technique
[24]. Five percent of samples were duplicates sent to the reference
laboratories as blinded samples for quality control purposes.
Microalbuminuria was defined as albumin/creatinine ratios  30
and < 300 mg albumin/g creatinine. Macroalbuminuria was
recognized as albumin concentrations  300 mg/g creatinine.
Insulin was measured using antibody 1012, WHO-traceable
(1988) insulin standards and supplies purchased from Linco
Research, Inc. (St. Louis, MO, USA). The interassay and intra-
assay coefficients of variation of the insulin assay at midrange were
8.5% and 2.2%, respectively. Technical errors (coefficient of
variation between blinded pairs) for the plasma measurements
were as follows: cholesterol 5.8%, triglycerides 10.2%, fibrinogen
12.4%, urine creatinine 8.7%, urine albumin 6.4% and fasting
plasma glucose 13.6%.
Height and weight were measured with the participant in light
clothing with shoes removed. Waist circumference was obtained
at the umbilicus with the participant in the supine position. Hip
circumference was measured over light clothing while the partic-
ipant was standing: the greatest diameter around the buttocks was
recorded. Electrical impedance was estimated by use of an RJL
Impedance Meter (Model B14101, RJL Equipment Co., Detroit,
MI, USA) and percent body fat was calculated using the Segal
formula [25]. Blood pressure measurements (Baum Sphygmoma-
nometer Co. Copiaque, NY, USA) were obtained according to
A.H.A. standardized protocol in the right arm with the participant
in the sitting position, and after five minutes of rest. Participants
were considered to have definite hypertension if they had a
systolic BP  140 mm Hg, or a diastolic BP  90 mm Hg, or if
they were taking antihypertensive medication. Indian heritage was
expressed as percent of Indian blood and based on self-reported
data obtained during the interview. Normal, overweight and
obesity were classified on the basis of body mass index [26].
Significance of center-specific differences was evaluated by
analysis of variance. Univariate analyses were first performed to
describe albuminuria. Analysis of variance and multiple compar-
ison of means were used to compare the differences among
subgroups. The chi-square test was used to compare the preva-
lence rates. Ninety-five percent confidence intervals were con-
structed for means of continuous variables. Stepwise logistic
regression was employed to simultaneously adjust the covariates
and determine their relative significance.
Results
A detailed description of the characteristics of the study
population is published elsewhere [18]. Briefly, fifty percent of the
participants were from the lower decade of age, 45 to 54 years.
The mean (SD) ages were 55.7 (7.9) in Arizona, 56.8 (8.3) in
Oklahoma and 56.5 (8.0) in North/South Dakota. Approximately
equal numbers of participants (1500 in Arizona, 1527 in Okla-
homa, 1522 in North/South Dakota) were studied at each site, but
there was a slight preponderance (59%) of women at all sites.
A strikingly large proportion of the examinees were diabetic,
and the distribution of diabetes by age, sex and site is shown in
Table 1. Among the total study population 53% were classified as
diabetic on the basis of known diabetes or a diabetic glucose
tolerance test. The greatest prevalence, by far, was detected in
Arizona (P < 0.0001). In each site, the prevalence rates for
women were higher than for men, and the gender difference was
significant at all study sites.
There were some small but highly significant differences in
mean blood pressure at the three sites (Table 2). Mean systolic
blood pressure (SBP) and and diastolic blood pressure (DBP)
were higher in Arizona and Oklahoma than in the Dakotas in both
male and female participants (P < 0.0001). The prevalence of
hypertension was 42 to 47% in Arizona and Oklahoma, but only
about 27% in participants from the Dakotas (P < 0.01).
Table 2 also shows the mean BMIs and percent body fat for the
study populations. In general, the study populations were obese,
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Mean systolic BP 131 132 131 129 124 122
mm Hg
Hypertension % 44.2 42.5 46.7 42.3 27.2 27.6
Mean BMI 31.1 33.1 30.2 31.3 28.5 30.1
Mean % body fat 32.8 44.1 32.4 43.3 31.1 42.4
Mean WHR 0.97 0.96 0.96 0.93 0.98 0.94
346 331 283 160 29 15 202 36 9
38.7 36.0 25.3 81.5 13.0 5.6 79.6 16.2 4.2
35.0 33.1 31.9 80.7 10.5 8.8 88.7 9.4 1.9
34.3 38.6 27.1 66.7 23.1 10.3 82.1 14.3 3.6
323 148 76 216 26 5 576 40 6
61.8 27.5 10.6 90.3 9.7 0.0 93.7 5.1 1.2
57.4 25.8 16.8 92.5 3.0 4.5 95.1 3.9 1.0
57.3 29.0 13.8 75.9 20.7 3.5 82.6 17.4 0.0
303 135 78 210 20 5 675 41 5
57.6 29.4 12.8 92.4 7.6 0.0 92.7 6.6 0.6
64.1 20.2 15.7 88.3 5.2 6.5 92.8 6.2 1.0
50.9 30.6 18.5 82.9 17.1 0.0 90.5 8.3 1.2
and the fat distribution was predominantly in the upper body.
Participants in Arizona had significantly (P < 0.0001) higher
BMIs and percentages of body fat than those at the other two
sites.
Table 3 summarizes the prevalence of normal, micro- and
macroalbuminuria within each site by age. Data were available
from slightly more than 1400 participants from each site. Among
the categories shown, about 35 to 65% of those with diabetes had
either micro- or macroalbuminuria. Several trends were evident.
Abnormal albuminuria was most prevalent among those with
diabetes. Those with impaired glucose tolerance generally had
higher rates than those with normal glucose tolerance. In addi-
tion, the prevalence rates of abnormal albuminuria in almost
every category were higher in Arizona than in the other two sites.
Table 4 summarizes the prevalence of abnormal albuminuria
among diabetic participants by duration of diabetes, fasting
plasma glucose, hypertension, body mass index and plasma fibrin-
ogen concentrations. The overall prevalence rates among the
participants are displayed in the first row. The distribution of
albuminuria was associated with each of these variables, but
within categories of each of them, the distribution of abnormal
albuminuria was shifted toward higher values in the Arizona sites
(P < 0.001 for association with site, stratified by each of the other
variables shown in the table, by the Mantel-Haenszel test). For
example, even among those who were normotensive, non-obese or
nondiabetic, rates of micro- and macroalbuminuria were highest
Ariz
micro
ona Oklahoma
macro micro macro
Da
micro
kotas
macro
All participants
Prevalence of abnormal 28.3 20.0 15.2 6.1 13.8 6.3
albuminuria
Diabetic participants only
Duration of DM years
0—4 32.2 8.2 18.4 7.1 22.0 6.0
5—9 44.7 20.0 30.2 11.5 35.8 14.7
10—14 34.6 25.4 39.8 15.9 25.0 23.5
>15 33.8 47.9 32.7 30.0 29.3 41.3
Fasting P1. glucose mg/dl
<110 21.6 37.3 10.6 10.6 21.6 11.8
111—139 27.0 19.2 18.7 11.4 13.9 9.9
>139 37.9 29.1 31.8 15.0 30.3 17.4
Hypertension
No 37.3 18.8 23.1 8.4 25.2 9.4
Yes 33.3 38.0 30.4 17.7 27.5 25.3
Body mass indexa
Normal 37.5 36.1 28.7 16.7 29.2 16.2
Overweight 34.9 33.1 25.7 12.5 27.0 13.8
Obese 34.3 20.1 27.4 13.2 23.6 15.6
Fibrinogen
Lower 1/3 30.5 12.4 28.1 8.5 24.6 8.6
Middle 1/3 46.3 18.5 26.8 7.7 28.1 14.4
Top 1/3 30.0 43.5 26.0 28.6 26.7 31.4
a Body mass index categories
Normal Overweight Obese
men <27.8 27.8—31.0 >31.1
women <27.3 27.3—32.2 >32.3
among participants in Arizona. Further evidence for the higher
rates of albuminuria in Arizona is found in Table 5 where medians
of albumin/creatinine ratios among the participants are shown by
site, and stratified within categories of variables thought to be
associated with albuminuria. Median albumin/creatinine ratios
were higher among Arizona participants for each of the catego-
ries; median albumin/ereatinine ratios were highest in Arizona
even among the youngest (45 to 54 years of age), normotensive
and those with the lowest levels of glycemia. Figure 1 shows the
relative frequencies of albuminuria among the three sites strati-
fied by glucose tolerance. In each glucose tolerance category,
higher ratios of urinary albumin/creatinine values were more
common among participants in Arizona than in the other two
sites. Conversely, normal ratios of albumin/creatinine were less
common among participants from Arizona within each of the
glucose tolerance categories.
Figure 2 shows the prevalence of albuminuria by Indian heri-
tage. Those with greater percentages of Indian blood also had the
highest prevalence of albuminuria (micro + macro). This trend is
especially evident in the Dakotas and Oklahoma where non-
Indian admixture was more common. The trend was least evident
in Arizona where non-Indian admixture was quite uncommon. In
Arizona, less than 10% of the participants reported that they
were not full-blooded Indians. The significance of the trend was
tested with the Cochran-Armitage test of the hypothesis that
the prevalence is not linearly related to the degree of Indian
heritage. Quartile scores of reported heritage were assumed to
be equally spaced categories. Within each site, Indian heritage
was significantly associated with albuminuria (P < 0.05) among
Table 2. Mean blood pressure, hypertension and obesity by site
Arizona Oklahoma Dakotas
Men Women Men Women Men Women
Table 4. Prevalence (%) of abnormal albuminuria
a By JNC-V criteria; SBP > 140, dBP > 90 or taking antihypertensive
medications
Table 3. Prevalence rates of albuminuria by age and site
DM IGT NOT
nI micro macro nI micro macro nl micro macro
Arizona
total 1411
N
45—54
55—64
65—74
Oklahoma
total 1416
N
45—54
55—64
65—74
Dakotas
total 1472
N
45—54
55—64
65—74
Normal Micro Macro
NGT
3o
I
0
1 3 10 30 100300100030001000030000
Normal Micro
-
Macro
40 CT
4111 It.h . I
1 3 10 30 100 300 1000 3000 10000 30000
Normal Micro Macro
-
10
L
1 3 10 30 100 300 1000 3000 10000 30000
Urine albumin (mg)/creatinine (g)
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Table 5. Median albumin/creatinine ratio (mg/g) by age, SBP, FPG in
all participants and duration of DM in diabetic participants only
Arizona Oklahoma Dakotas
Age
45—54 22.3 7.5 6.3
55—64 33.3 8.4 7.7
65 33.8 13.3 12.1
SBP
140 18.7 7.3 6.7
140—159 62.7 14.1 11.8
160 311.2 31 76.3
FPG
110 10.1 6.5 5.4
111—139 13.8 7.3 7.5
140 71.2 24.9 27.7
DM duration
0—4 19.9 11.8 13.2
5—10 56.2 23.1 26.8
10—15 69.9 39.3 46.8
15 294.7 92.1 123.4
those with diabetes. Among those with IGT or normal glucose
tolerance, the association was significant only in Oklahoma (P =
0.01).
The prevalence odds ratios comparing the participants in the
upper quartiles to those in the lower quartiles of several variables
associated with albuminuria is summarized in Table 6. In this
analysis, it can be seen that those with higher blood sugars, blood
pressure and fibrinogen concentrations were at increased risk for
micro- or macroalbuminuria. In addition, men and those from
Arizona were more likely to have abnormal albuminuria. Inter-
estingly, neither hyperinsulinemia nor waist-hip ratio were signif-
icantly associated with albuminuria in this model. The duration of
diabetes, fasting plasma glucose, systolic blood pressure and
fibrinogen were the four most powerful and consistent correlates
of albuminuria.
Discussion
This cross sectional study demonstrates a high prevalence of
abnormal albuminuria among these groups of older American
Indians. Prevalence rates in Arizona were significantly different,
with much higher rates of macroalbuminuria and microalbumin-
uria than the other two centers. Abnormal albuminuria was
strongly associated with diabetes and systolic hypertension at all
three sites, but albuminuria was clearly more common even
among Arizona participants who were non-diabetic and normo-
tensive than similar participants in the Dakotas or Oklahoma.
Furthermore, macro- and microalbuminuria were significantly
more common among participants who reported high degrees of
Indian heritage.
The high prevalence of microalbuminuria and macroalbumin-
uria found among Strong Heart Study participants is consistent
with earlier observations detecting high prevalence rates of end-
stage renal disease and proteinuria among several Indian groups
including the Pima-Papago tribes in Arizona. For example, Nel-
son and associates reported on the prevalence of albuminuria
among 2728 participants studied between 1982 and 1988 in the
Gila River Indian Community in Arizona [12]. The study cohort
included participants as young as 15 years and the mean age was
younger than that of the Strong Heart Study. Using the same assay
methods and definitions of micro and macroalbuminuria as this
Fig. 1. The relative frequencies of categories of albuminuria expressed by the
ratio of urine albumin to creatinine concentrations found among the three
study sites. The uppermost, middle and lower panels summarize the
distributions among the participants with normal (NGT), impaired (IGT)
or diabetic (DM) glucose tolerance, respectively. Within each graph panel,
separate vertical bars indicate the frequency within each of the three sites(• Arizona; Oklahoma; ( South/North Dakota). The data show that
participants with normal amounts of albumin in the urine are less frequent
in Arizona than the other two sites. Conversely, micro- and macroalbu-
minuria are more commonly found among the Arizona Indians.
study, 13.1% of the subjects had inicroalbuminuria and 7.2% had
macroalbuminuria. Nearly 8% of those with normal glucose
tolerance had abnormal amounts of urine albumin. Nearly 47% of
70
60 -—
I NGT+IGT
50
40
30
i_±itL--
AZ OK S/ND
70
60
DM
50
40
30
20
10
0
AZ OK S/ND
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Fig. 2. The prevalence of albuminuria is shown
within each site according to quartile of reported
Indian heritage. Symbols are: (LII) 0 to 49%; ()
50 to 74%; () 75 to 99%; () 100%. Most
participants in Arizona were full- or nearly full-
blooded, and thus some categories had no
reported participants (NGT + IGT: AZ 0 to
49% and 75 to 99%; DM: AZ 0 to 49%). Note
that increasing amounts of reported Indian
heritage was associated with a higher
prevalence of albuminuria.
diabetic participants had some degree of abnormal albuminuria.
Albuminuria was significantly associated with age, duration of
diabetes, glycemia, blood pressure and insulin use.
While the Pima Indians may have the highest known prevalence
of albuminuria, other Indian tribes also have higher prevalence
rates of end-stage renal disease in comparison to whites, and the
incidence appears to be increasing. The prevalence of end-stage
renal disease among American Indians is a least 2.8 times that of
the general population [14] and the incidence is said to be
increasing at a rate of 17% per year [27]. The incidence among
Pima Indians is 23 times that of the U.S. population [28].
The strong, independent association of albuminuria with
plasma fibrinogen concentrations was anticipated; fibrinogen is
thought to be an acute-phase reactant as part of the pathologic
process of renal damage and vascular injury [29—31]. Our cross
sectional data do not allow us to determine, with any confidence,
if fibrinogen levels predict albuminuria. Follow-up studies, as part
of phase II of the Strong Heart Study, are underway, and they will
help determine the precise role, if any, for fibrinogen in producing
susceptibility to abnormal albuminuria.
The association of Indian admixture with disease is complex.
Although we found a close association of albuminuria with
reported Indian heritage, there was no clear relationship of Indian
Heritage to coronary heart disease prevalence in the same study
population [19]. In contrast to cardiac disease, diabetes and
impaired glucose tolerance were directly related to Indian heri-
tage [20, 32].
We cannot, with the current data, determine if environmental
factors account for some or possibly all of the site to site
differences in renal dysfunction. Such factors as dietary sodium,
protein and fat intake could not be reliably measured in phase I of
the Strong Heart Study since only a limited number in each site
underwent dietary assessment. A yet to be identified environmen-
tal toxin could also be hypothesized.
One of the most interesting aspects of this study is the detection
of higher rates of macro- or microalbuminuria among nondiabetic
562 Robbins et al: Albuminuria among American Indians
Table 6. Prevalence odds ratios of albuminuria derived from a multiple logistic regression analysis
P Qi mean Q4 mean
Odds ratio
exp(beta*Q4Q1) Lower 95% Upper 95%
Abnormal albuminuria (micro + MACRO
N = 1274 vs. 2994 normal),
all participants in all three centers
Fasting plasma glucose 0.0001 92.0 262.9 7.915 6.541 9.578
SBP 0.0001 106.0 154.1 4.343 3.522 5.355
Age 0.0710 46.9 67.7 1.215 0.984 1.502
Plasma insulin 0.5859 6.5 44.3 1.038 0.908 1.187
Fibrinogen 0.0001 215.5 404.8 3.131 2.549 3.845
Indian Heritage 0.0001 0.0 34.5 1.393 1.186 1.636
WHR 0.2451 0.9 1.0 1.136 0.916 1.410
Arizona (1,0) 0.0001 0 1 1.802 1.518 2.139
Sex (F = 1, M = 0) 0.0113 0 1 0.803 0.678 0.952
Abnormal albuminuria (micro + MACRO
N = 963 vs. 927 normal),
diabetic participants only in all three centers
Fasting plasma glucose 0.0001 92.0 262.9 3.568 2.774 4.589
SBP 0.0001 106.0 154.1 4.219 3.152 5.647
Age 0.0842 46.9 67.7 0.769 0.570 1.037
Plasma insulin 0.2570 6.5 44.3 0.916 0.786 1.067
Fibrinogen 0.0001 215.5 404.8 2.930 2.207 3.890
Indian Heritage 0.0190 0.0 34.5 1.333 1.048 1.694
WHR 0.5377 0.9 1.0 1.098 0.815 1.488
Arizona (1,0) 0.0192 0 1 1.314 1.045 1.652
Sex (F = 1, M = 0) 0.0008 0 1 0.677 0.539 0.851
DM duration 0.0001 0.1 23.3 4.402 3.227 6.005
and non-hypertensive participants in Arizona. Nelson and col-
leagues also found a high prevalence among non-diabetic Pima
Indians in the Gila River Indian Community [121. While the
prevalence of abnormal albuminuria (micro- or macroalbumin-
uria) was higher in those with impaired glucose tolerance (15%)
than in those with normal glucose tolerance (8%), the majority of
cases among the nondiabetic subjects occurred in those with
normal glucose tolerance and hence could not be attributed to
clinically apparent hyperglycemia. Thus, additional explanations
must be considered. For example, early renal disease may in some
individuals be independent of diabetes. The later occurrence of
diabetes, hypertension or introduction of certain environmental
factors may then accelerate the renal damage and lead to pro-
gressive nephropathy. This hypothesis is supported by the obser-
vation in Pima Indians that blood pressure measured before the
onset of diabetes predicted a greater prevalence of abnormal
albuminuria after the onset of diabetes [331.
The potential public health implications of our observations are
immense. In general, type I diabetic individuals with abnormal
albuminuria have significantly increased risks of coronary heart
disease [2, 4, 34], proliferative retinopathy [35], and accelerated
progression to end-stage renal disease [71. The presence of
albuminuria (micro + macro) was significantly associated (P S
0.04) with definite and possible coronary heart disease within each
of the three Strong Heart Study sites (Howard, manuscript
submitted). The apparent clustering of complications with albu-
minuria has raised the possibility that albuminuria is simply a
reflection of a more widespread vasculopathy affecting the heart,
eyes and kidneys [36]. It cannot be determined from these cross
sectional data whether the American Indians in the Strong Heart
Study, in whom non-insulin-dependent (type 2) diabetes predom-
inates, will follow a similar pattern of multi-organ deterioration
found in whites with type 1 diabetes mellitus. However, evidence
of progression from microalbuminuria to end-stage renal disease
among non-Indian diabetic individuals should raise considerable
concern. Furthermore, as shown by Neil and his colleagues,
microalbuminuria (40 to 200 mg/liter) is also a significant inde-
pendent predictor of mortality in those with diabetes during a
mean follow-up period of 6.1 years [1], and among Pima Indians,
the degree of albuminuria, even within the range classified as
normal or microalbuminuria, predicts worsening to overt protein-
uria [111, and nearly all the excess mortality associated with
non-insulin dependent diabetes occurred in those with overt
proteinuria [37].
In conclusion, there were significant differences in the preva-
lence of abnormal albuminuria between the three study sites, with
the highest prevalence among participants in Arizona. While
systolic hypertension and diabetes were clearly related to albu-
minuria, normotensive nondiabetic participants from Arizona
were more likely to have abnormal albuminuria than similar
participants from the other two sites. Indian heritage seemed to
be directly related to the presence of albuminuria, suggesting a
genetic susceptibility to renal disease. Further work is needed to
define the genetic and or environmental factors that lead to renal
impairment. This information may be helpful in coping with a
potentially large and unfortunate disease burden falling on these
Indian communities.
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